Shire plc (LSE: SHP, NASDAQ: SHPGY) announces that a recent additional analysis of clinical data presented at Digestive Disease Week (DDW) 2011 in Chicago, USA, reconfirm that Resolor® (prucalopride), is efficacious in women with chronic constipation in whom laxatives do not provide adequate relief.1 Once-daily prucalopride (2 mg) improves bowel function and bowel symptoms, and also improves ...
Constipation is definitely not a glamorous topic. In reality, it affects nearly 30 million Americans and costs more than $1 billion annually to evaluate and treat. While not often life threatening, the pain, bloating, discomfort, and straining associated with constipation lead sufferers to focus on one thing - relief. Mayo Clinic researchers recently had success in the clinical trial of a new ...
Washington, May 11 (IANS) The acute bloating, discomfort and straining associated with constipation may soon be a thing of the past, thanks to a new drug.
Irritable bowel syndrome, or IBS, can be anywhere from annoying to downright debilitating making everyday situations fraught with anxiety. Millions suffer from IBS, which can cause on-going constipation, diarrhea, gas, bloating, or any combination of the above. But good news, IBS … Read More
Constipation is definitely not a glamorous topic. In reality, it affects nearly 30 million Americans and costs more than $1 billion annually to evaluate and treat. While not often life threatening, the pain, bloating, discomfort, and straining associated with constipation lead sufferers to focus on one thing - relief.
| |